ArticleJournal of clinical medicine2021

The Long-Term Effectiveness of Omalizumab in Adult Patients with Severe Allergic Asthma: Continuous Treatment Versus Boosting Treatment.

Wei-Chang Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.